Surveillance of metastatic lung cancer after curative treatments – pro
Not much is known about how to follow metastatic lung cancer that has been in remission after curative3 treatment because this situation is uncommon and was unheard of before new treatments were approved and began to be used several years ago. In the first year, radiological follow-up should be considered every 6–12 weeks to allow for an early initiation of second-line therapy. After that, standard guidelines do not offer recommendations.
M. Reck, S. Popat, N. Reinmuth, D. De Ruysscher, K. M. Kerr, S. Peters, Metastatic Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines, 2014 – Ann Oncol (2014) 25 (suppl 3): iii27-iii39.
Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e437S-54S.
S. Peters et al, Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 23 (suppl 7): vii56-vii64.